Denali Therapeutics (DNLI) P/E (2018 - 2026)
Denali Therapeutics (DNLI) P/E from Jan 2, 2018 to Jul 21, 2026. The TTM Denali Therapeutics (DNLI) P/E is -7.11. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Denali Therapeutics (DNLI)
| Year | P/E | Change |
|---|---|---|
| 2026 | -7.11 | +48.90% |
| 2025 | -4.78 | -30.92% |
| 2024 | -6.92 | -70.57% |
| 2023 | -23.50 | +107.70% |
| 2022 | -11.31 | -39.47% |
| 2021 | -18.69 | -110.11% |
| 2020 | 184.90 | -2289.43% |
| 2019 | -8.45 | -83.67% |
| 2018 | -51.72 | N/A |
Comparison Denali Therapeutics (DNLI) P/E with competitors
Denali Therapeutics (DNLI) P/E is -7.11.